Results of Experimental Ligation of the Main Vein with the Use of Cell Technologies


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Autologous multipotent mesenchymal stromal cells (MMSC) of bone marrow origin with transfected GFP gene and additionally stained cell membranes were injected to rats through the skin in the projection of ligated femoral vein. The results were evaluated by fluorescent microscopy. No signs of MMSC incorporation into the wall of ligated vessel or reorganized collaterals were detected. Angiogenesis processes involving MMSC were detected in experimental rats within just 4 days and progressed until week 2 postinjection, mainly in granulations at the site of surgical intervention and the cicatrix forming there. Injected MMSC completely formed all tunics of the new vessels and incorporated in the vessels forming from the recipient cells. MMSC and the objects created from them were gradually eliminated with participation of macrophages and replaced by structures formed from the recipient cells.

About the authors

I. V. Maiborodin

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Author for correspondence.
Email: imai@mail.ru
Russian Federation, Novosibirsk

V. V. Morozov

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

V. A. Matveeva

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

A. A. Anikeev

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

N. F. Figurenko

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

R. V. Maslov

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

G. A. Chastikin

Center of New Medical Technologies, Institute of Chemical Biology and Basic Medicine, Siberian Division of the Russian Academy of Sciences

Email: imai@mail.ru
Russian Federation, Novosibirsk

V. I. Maiborodina

Laboratory of Ultrastructural Bases of Pathology, Institute of Molecular Pathology and Pathomorphology

Email: imai@mail.ru
Russian Federation, Novosibirsk


Copyright (c) 2017 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies